Total and unopposed estrogen exposure across stages of the transition to menopause

Cancer Epidemiology Biomarkers and Prevention

Volumn 18, Issue 3, 2009, Pages 828-836

  O'Connor, Kathleen A ^a   Ferrell, Rebecca J ^b   Brindle, Eleanor ^a   Shofer, Jane ^a   Holman, Darryl J ^a   Miller, Rebecca C ^b   Schechter, Deborah E ^a   Singer, Burton ^c   Weinstein, Maxine ^d  

^a UNIVERSITY OF WASHINGTON   (United States)

^b TEMPLE UNIVERSITY HOSPITAL   (United States)

^c PRINCETON UNIVERSITY   (United States)

^d GEORGETOWN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN; ESTRONE GLUCURONIDE; DRUG DERIVATIVE; ESTRONE; ESTRONE-3-GLUCURONIDE; PREGNANEDIOL; PREGNANEDIOL 3 ALPHA GLUCURONIDE; PREGNANEDIOL-3 ALPHA-GLUCURONIDE;

ADULT; ARTICLE; BODY MASS; ESTROGEN BLOOD LEVEL; ESTROGEN URINE LEVEL; FEMALE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MENOPAUSE; MENSTRUAL CYCLE; POSTMENOPAUSE; PRIORITY JOURNAL; PROSPECTIVE STUDY; REPRODUCTION; URINALYSIS; ALGORITHM; MIDDLE AGED; PHYSIOLOGY; TIME; URINE;

ADULT; ALGORITHMS; ESTRONE; FEMALE; HUMANS; MENOPAUSE; MIDDLE AGED; PREGNANEDIOL; TIME FACTORS;

EID: 64549112252     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-08-0996     Document Type: Article

References (57)

1. Surveillance, Epidemiology and End Results (SEER) Program. SEER*Stat database: incidence-SEER 17 Regs limited-use, Nov 2006 Sub (2000-2004). National Cancer Institute, DCCPS, Surveillance Research Program, Cancer Statistics Branch, released 2007, based on the November 2006 submission. Available from: www.seer.cancer.gov.
2. Henderson BE, Ross RK, Pike MC, Casagrande JT. Endogenous hormones as a major factor in human cancer. Cancer Res 1982;42:3232-3239 (Pubitemid 12041084)
3. Key TJ. Hormones and cancer in humans. Mutat Res 1995;333:59-67.
4. Ursin G, Wilson M, Henderson BE, et al. Do urinary estrogen metabolites reflect the differences in breast cancer risk between Singapore Chinese and United States African-American and White women? Cancer Res 2001;61:3326-3329
5. Pike MC, Pearce CL, Peters R, Cozen W, Wan PC, Wu AH. Hormonal factors and the risk of invasive ovarian cancer: a population-based case-control study. Fertil Steril 2004;82:186-195 (Pubitemid 38968797)
6. Eliassen AH, Missmer SA, Tworoger SS, et al. Endogenous steroid hormone concentrations and risk of breast cancer among premenopausal women. J Natl Cancer Inst 2006;98:1406-1415 (Pubitemid 44530717)
7. Lukanova A, Kaaks R. Endogenous hormones and ovarian cancer: epidemiology and current hypotheses. Cancer Epidemiol Biomarkers Prev 2005;14:98-107. (Pubitemid 40165289)
8. Persson I. Estrogens in the causation of breast, endometrial and ovarian cancers - evidence and hypotheses from epidemiological findings. J Steroid Biochem Mol Biol 2000;74:357-364 (Pubitemid 32126247)
9. Henderson BE, Feigelson HS. Hormonal carcinogenesis. Carcinogenesis 2000;21:427-433 (Pubitemid 30137927)
10. Henderson BE, Ross R, Bernstein L. Estrogens as a cause of human cancer: the Richard and Hinda Rosenthal Foundation award lecture. Cancer Res 1988;48:246-253 (Pubitemid 18045752)
11. Prior JC. Perimenopause: the complex endocrinology of the menopausal transition. Endocr Rev 1998;19:397-428.
12. McKinlay SM, Brambilla DJ, Posner JG. The normal menopause transition. Am J Hum Biol 1992;4:37-46.
13. Hale GE, Hughes CL, Cline JM. Endometrial cancer: hormonal factors, the perimenopausal "window of risk," and isoflavones. J Clin Endocrinol Metab 2002;87:3-15. (Pubitemid 34084662)
14. Pike MC. Age-related factors in cancers of the breast, ovary, and endometrium. J Chronic Dis 1987;40 Suppl 2:59-69S. (Pubitemid 17143403)
15. Sherman BM, Koreman SG. Inadequate corpus luteum function: a pathophysiological interpretation of human breast cancer epidemiology. Cancer 1974;33:1306-1312
16. Park SJ, Goldsmith LT, Weiss G. Age-related changes in the regulation of luteinizing hormone secretion by estrogen in women. Exp Biol Med 2002;227:455-464
17. Weinstein M, Gorrindo T, Riley A, et al. Timing of menopause and patterns of menstrual bleeding. Am J Epidemiol 2003;158:782-791 (Pubitemid 37237242)
18. Klein NA, Soules MR. Endocrine changes of the perimenopause. Clin Obstet Gynecol 1998;41:912-920 (Pubitemid 29320433)
19. Santoro N. The menopausal transition. Am J Med 2005;118 Suppl 12B:8-13. (Pubitemid 43083576)
20. Shideler SE, DeVane GW, Kaira PS, Benirschke K, Lasley BL. Ovarian-pituitary hormone interactions during the perimenopause. Maturitas 1989;11:331-339 (Pubitemid 20018233)
21. Santoro N, Adel T, Skurnick JH. Decreased inhibin tone and increased activin A secretion characterize reproductive aging in women. Fertil Steril 1999;71:658-662 (Pubitemid 29149415)
22. Santoro N, Brown JR, Adel T. Characterization of reproductive hormonal dynamics in the perimenopause. J Clin Endocrinol Metab 1996;81:1495-1501 (Pubitemid 26118582)
23. Welt CK, McNicholl DJ, Taylor AE, Hall JE. Female reproductive aging is marked by decreased secretion of dimeric inhibin. J Clin Endocrinol Metab 1999;84:105-111 (Pubitemid 29036687)
24. Hale GE, Zhao X, Hughes CL, Burger HG, Robertson DM, Fraser IS. Endocrine features of menstrual cycles in middle and late reproductive age and the menopausal transition classified according to the Staging of Reproductive Aging Workshop (STRAW) staging system. J Clin Endocrinol Metab 2007;92:3060-3067 (Pubitemid 47236371)
25. Sherman BM, West JH, Korenman SG. The menopausal transition: analysis of LH, FSH, estradiol, and progesterone concentrations during menstrual cycles of older women. J Clin Endocrinol Metab 1976;42:629-636
26. Burger HG, Dudley E, Hopper JL, et al. Prospectively measured levels of serum follicle-stimulating hormone, estradiol and the dimeric inhibins during the menopausal transition in a population-based cohort of women. J Clin Endocrinol Metab 1999;84:4025-4030 (Pubitemid 30644189)
27. Burger HG, Dudley E, Hopper JL, et al. The endocrinology of the menopausal transition: a cross-sectional study of population-based sample. J Clin Endocrinol Metab 1995;80:3537-3545
28. Randolph JF Jr, Sowers M, Bondarenko IV, Harlow SD, Luborsky JL, Little RJ. Change in estradiol and follicle-stimulating hormone across the early menopausal transition: effects of ethnicity and age. J Clin Endocrinol Metab 2004;89:1555-1561 (Pubitemid 38507902)
29. Overlie I, Moen MH, Morkrid L, Skjaeraasen JS, Holte A. The endocrine transition around menopause - a five years prospective study with profiles of gonadotropines, estrogens, androgens and SHBG among healthy women. Acta Obstet Gynecol Scand 1999;78:642-647 (Pubitemid 29322477)
30. Hall Moran V, Leathard HL, Coley J. Urinary hormone levels during the natural menstrual cycle: the effect of age. J Endocrinol 2001;170:157-164 (Pubitemid 32677577)
31. Reyes FI, Winter JS, Faiman C. Pituitary-ovarian relationships preceding the menopause. I. A cross-sectional study of serum follicle-stimulating hormone, luteinizing hormone, prolactin, estradiol, and progesterone levels. Am J Obstet Gynecol 1977;129:557-564
32. Santoro N, Isaac B, Neal-Perry G, et al. Impaired folliculogenesis and ovulation in older reproductive aged women. J Clin Endocrinol Metab 2003;88:5502-5509 (Pubitemid 37452762)
33. Klein NA, Battaglia DE, Fujimoto VY, Davis GS, Bremner WJ, Soules MR. Reproductive aging: accelerated ovarian follicular development associated with a monotropic follicle-stimulating hormone rise in normal older women. J Clin Endocrinol Metab 1996;81:1038-1045 (Pubitemid 26083969)
34. Reame NE, Wyman TL, Phillips DJ, de Kretser DM, Padmanabhan V. Net increase in stimulatory input resulting from a decrease in inhibin B and an increase in activin A may contribute in part to the rise in follicular phase follicle-stimulating hormone of aging cycling women. J Clin Endocrinol Metab 1998;83:3302-3307 (Pubitemid 28500976)
35. Bjornerem A, Straume B, Midtby M, et al. Endogenous sex hormones in relation to age, sex, lifestyle factors, and chronic diseases in a general population: the Tromso Study. J Clin Endocrinol Metab 2004;89:6039-6047 (Pubitemid 39628412)
36. Ferrell RJ, O'Connor KA, Rodríguez G, et al. Monitoring reproductive aging in a five year prospective study: aggregate and individual changes in steroid hormones and menstrual cycle lengths with age. Menopause 2005;12:567-577 (Pubitemid 41362081)
37. Soules MR, Sherman S, Parrott E, et al. Executive summary: Stages of Reproductive Aging Workshop (STRAW). Fertil Steril 2001;76:874-878 (Pubitemid 33031310)
38. Mansfield PK, Bracken SL. TREMIN: a history of the world's oldest ongoing study of menstruation and women's health. Lemont (PA): East Rim Publishers; 2003.
39. O'Connor KA, Brindle E, Holman DJ, et al. Urinary estrone conjugate and pregnanediol-3-glucuronide enzyme immunoassays for population research. Clin Chem 2003;49:1139-1148 (Pubitemid 36751101)
40. O'Connor KA, Brindle E, Shofer JB, et al. Statistical correction for non-parallelism in a urinary enzyme immunoassay. J Immunoassay Immunochem 2004;25:259-278 (Pubitemid 39202467)
41. Miller RC, Brindle E, Holman DJ, et al. Comparison of specific gravity and creatinine methods for normalizing urinary reproductive hormone concentrations. Clin Chem 2004;50:924-932 (Pubitemid 38543672)
42. O'Connor KA, Brindle E, Miller RC, et al. Ovulation detection methods for urinary hormones: precision, daily and intermittent sampling and a combined hierarchical method. Hum Reprod 2006;21:1442-1452 (Pubitemid 44445020)
43. Miro F, Parker SW, Aspinall LJ, Coley J, Perry PW, Ellis JE. Origins and consequences of the elongation of the human menstrual cycle during the menopausal transition: the FREEDOM study. J Clin Endocrinol Metab 2004;89:4910-4915 (Pubitemid 39391427)
44. Lisabeth L, Harlow S, Gillespie B, Lin X, Sowers M. Staging reproductive aging a comparison of bleeding criteria. Menopause 2004;11:186-197
45. Key T, Appleby P, Barnes I, Reeves G. Endogenous sex hormones and breast cancer in postmenopausal women: reanalysis of nine prospective studies. J Natl Cancer Inst 2002;94:606-616 (Pubitemid 34498648)
46. Missmer SA, Eliassen AH, Barbieri RL, Hankinson SE. Endogenous estrogen, androgen, and progesterone concentrations and breast cancer risk among postmenopausal women. J Natl Cancer Inst 2004;96:1856-1865 (Pubitemid 40081323)
47. Henderson BE, Bernstein L, Ross R. Etiology of cancer: hormonal factors. In: DeVita VT, Hellman S, Rosenberg SA, editors. Cancer: principles and practice of oncology. Philadelphia: Lippincott-Raven; 1997. p. 219-229
48. Metcalf MG, Donald RA, Livesey JH. Pituitary-ovarian function before, during, and after the menopause: a longitudinal study. Clin Endocrinol 1982;17:489-494 (Pubitemid 12030382)
49. Metcalf MG, Mackenzie JA. Menstrual cycle and exposure to oestrogens unopposed by progesterone. J Endocrinol 1985;104:137-141
50. Key TJA, Pike MC. The dose-effect relationship between "unopposed" oestrogens and endometrial mitotic rate. Br J Cancer 1988;57:205-212
51. Pike MC, Ross RK. Progestins and menopause: epidemiological studies of risks of endometrial and breast cancer. Steroids 2000;65:659-664
52. Brewster AM, Do KA, Thompson PA, et al. Relationship between epidemiologic risk factors and breast cancer recurrence. J Clin Oncol 2007;25:4438-4444 (Pubitemid 350013850)
53. Weiss G, Skurnick JH, Goldsmith LT, Santoro N, Park SJ. Menopause and hypothalamic-pituitary sensitivity to estrogen. JAMA 2004;292:2991-2996 (Pubitemid 39665300)
54. Key TJ, Appleby PN, Reeves GK, et al. Body mass index, serum sex hormones, and breast cancer risk in postmenopausal women. J Natl Cancer Inst 2003;95:1218-1226 (Pubitemid 37069552)
55. Wing RR, Matthews KA, Kuller LH, Meilahn EN, Plantinga PL. Weight gain at the time of menopause. Arch Intern Med 1991;151:97-102.
56. Sowers M, Zheng H, Tomey K, et al. Changes in body composition in women over six years at midlife: ovarian and chronological aging. J Clin Endocrinol Metab 2007;92:895-901. (Pubitemid 46465660)
57. Gorrindo T, Lu Y, Pincus S, et al. Lifelong menstrual histories are typically erratic and trending: a taxonomy. Menopause 2007;14:74-88. (Pubitemid 46072008)